Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | AMGN | VRTX | REGN | BMY |
| Company | Orphazyme A/S ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.9060 | 313.39 | 401.50 | 926.94 | 43.90 |
| High | 0.9571 | 322.60 | 405.67 | 947.08 | 44.33 |
| Low | 0.8457 | 310.65 | 397.80 | 926.94 | 43.81 |
| Last | 0.8700 | 311.96 | 398.33 | 939.33 | 43.75 |
| Change | -0.0200 | +33.57 | -1.83 | +1.72 | +0.05 |
| % Change | -2.25% | +12.06% | -0.46% | +0.18% | +0.11% |
| Volume | 941,400 | 4,242,492 | 156,693 | 83,839 | 2,624,490 |
| 20-Day Average Volume | 1,980,090 | 2,347,617 | 975,047 | 493,766 | 13,938,023 |
| Previous Close | 0.8900 | 278.39 | 400.16 | 937.61 | 43.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 272.46 | 398.40 | 909.07 | 47.48 |
| 20-Day Raw Stochastic | 41.76% | 87.86% | 59.41% | 88.91% | 10.99% |
| 20-Day Relative Strength | 36.52% | 73.33% | 46.63% | 55.11% | 30.79% |
| Weighted Alpha | -87.89 | +35.91 | +14.12 | +23.84 | -36.15 |
| Today's Opinion | 100% Sell | 24% Buy | 8% Buy | 48% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 16% Sell | 8% Buy | 48% Buy | 88% Sell |
| Last Month's Opinion | 100% Sell | 24% Sell | 24% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | +16.71% since 04/26/24 | +0.75% since 04/26/24 | +6.54% since 04/26/24 | -1.34% since 04/26/24 |
| Low | 0.8275 on 03/29/22 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 883.20 on 04/29/24 | 43.33 on 05/02/24 |
| High | 0.9600 on 03/29/22 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 947.08 on 05/03/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | +14.82% since 04/03/24 | -2.04% since 04/03/24 | -1.05% since 04/03/24 | -15.20% since 04/03/24 |
| Low | 0.5101 on 03/14/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 1.3720 on 03/10/22 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 962.20 on 04/04/24 | 52.08 on 04/04/24 |
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | -2.51% since 02/02/24 | -5.70% since 02/02/24 | -0.44% since 02/02/24 | -9.16% since 02/02/24 |
| Low | 0.5101 on 03/14/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 2.7500 on 01/03/22 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | +16.76% since 11/03/23 | +6.45% since 11/03/23 | +15.19% since 11/03/23 | -16.22% since 11/03/23 |
| Low | 0.5101 on 03/14/22 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 5.4900 on 10/13/21 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 149,321,728 | 103,424,960 | 102,913,952 | 88,584,272 |
| Shares Outstanding, K | 35,312 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -97,010,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | N/A | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 1.68 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.20 on 02/05/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 04/05/22 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 24.04 | 42.10 |